Interleukine 6 as a Predictor of Outcome in Mechanically Ventilated Patients With Covid 19

Completed

• Conditions: Mechanical Ventilation Duration

• Registration Number: NCT05274503
• Lead Sponsor: Sohag University

Brief Summary

Serum IL-6 levels will be determined by enzyme-linked immunosorbent assay according to the manufacturer's instructions and the normal range is \<10 pg/mL , Patients' medical records will be carefully reviewed and analyzed. Patient data regarding demographics, comorbidities, signs and symptoms, laboratory results and complications will be collected. The occurrence of complications will be confirmed according to the following criteria: acute respiratory distress syndrome (ARDS) defined according to the Berlin definition

Detailed Description

Not available

Study Timeline

• Study Start: 2021-06-01
• Primary Completion: 2021-12-01
• Study Completion: 2022-01-01
• Status Verified: 2022-02
• Study First Submitted: 2022-03-09
• Study First Submitted QC: 2022-03-09
• Last Update Submitted: 2022-03-09
• Study First Posted: 2022-03-10
• Last Update Posted: 2022-03-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• •Age: more than 20 years.

  • Gender: both males and females will be included.
  • Mechanically Ventilated patients.
  • COVID 19 confirmed diagnosis

Exclusion Criteria

• •Immunocompromised patients.

  • Oxygen saturation more than 95% without ventilation.
  • Malignancy.
  • Patients refuse to be enrolled in the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
detection of acute respiratory distress syndrome	2 weeks	hypoxia, incresed plateau pressure

Trial Locations

Locations (1)

Sohag University, Faculty of Medicine; 🇪🇬 Sohag, Egypt